Skip to main navigation Skip to search Skip to main content

An Open Label, Multi-center clinical Trial of HuMax-CD4, a Fully Human Monoclonal Anti-CD4 Antibody, in Patients with Mycosis Fungoides Type CTCL (stage IB-IVB) Who are Refractory of Intolerant to Targretin (bexarotene) and One Other Standa

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date08/1/04 → 07/31/10

Funding

  • Genmab Incorporated: $21,072.20